Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
August 8th, 2025
An upper-extremity approach for secondary access during transfemoral transcatheter aortic valve implantation is associated with fewer secondary access site-related bleeding complications and reduces time to mobilization in patients requiring extended pacing. This protocol aims to provide an extensive overview of the upper-extremity approach and guide operators in adopting this methodology.
Our goals include refining our TAVI practices and improve overall procedural outcome. One of our aims was to reduce exercise complications and facilitate early mobilization and a quick rehabilitation. Inserting a temporary pacing lead in a manner that allows for early mobilization does not only enhance clinical outcomes, but also increases satisfaction among both patients and nursing staff.
Our current goal is to enhance diagnostic accuracy for para valvular regurgitation. By utilizing invasive hemodynamic measurements and creating a real time algorithm, we aim to more accurately detect and reduce para valvular regurgitation. To begin, instruct the patient to lie in a supine position on the catheterization table.
Fully extend the patient's left arm at a 90 degree angle relative to the thorax, maintaining the arm in the same vertical plane, and support the arm with an armrest. Instruct the patient to overextend and supinate the arm to present the medial ventral side of the upper arm to the operator. Disinfect the entire upper arm, using either chlorhexidine or povidone iodine, to prepare the access site and wrap a tourniquet around the upper arm as proximally as possible to enhance vein visibility.
Place a sterile cover that exposes only the disinfected upper arm to create a sterile field. Now prepare for ultrasound guided puncture by using a vascular probe, covering it with ultrasound gel and a sterile probe cover and applying sterile ultrasound gel to the access site. Use ultrasound to locate a suitable vein for puncture, typically found 5 to 10 centimeters proximal to the elbow crease.
Identify the basilic vein on the medial ventral side, or the cephalic vein on the lateral side as common choices. Choose a vein based on depth, giving preference to superficial veins, and select a vein with a larger diameter for easier puncture. After selecting a suitable vein, use the ultrasound probe to compress it and confirm it is a vein by ensuring it collapses under pressure.
Infiltrate the subcutaneous tissue at the desired access site with one to two milliliters of 1%lidocaine solution. Using direct ultrasound guidance, puncture the vein with a hollow needle from the six French sheath kit and confirm backflow. Immediately insert a guide wire through the hollow needle and advance it.
Then, remove the tourniquet and withdraw the hollow needle over the wire. Next, flush the sheath and side port thoroughly to ensure no air remains in the system. Introduce the six French sheath over the guide wire, and then remove the guide wire and dilator creating a six French lumen.
Use a five French flow directed pacing catheter with the balloon and introduce it deflated through the sheath and advance the pacing lead further. Use fluoroscopy in an anterior posterior zero degree view to guide the pacing lead toward the right ventricle. Continue advancing the pacing lead so it naturally follows the vascular path without resistance.
Once the lead tip reaches the subclavian vein, inflate the balloon to help steer it into the right ventricle. To pass through the tricuspid valve, rotate the pacing lead and guide the balloon tip through the valve while inflated. After the lead contacts the right ventricular apex, deflate the balloon.
When the pacing lead is properly positioned in the right ventricle, connect the electrode plugs to their corresponding ports on the adapter. Perform a capture threshold test by pacing at 20 beats per minute above the intrinsic heart rate at maximum pacemaker output. Gradually reduce the output amperage until mal capture is observed, indicated by a regular heartbeat or drop in heart rate below the pacemaker setting.
Ensure that the pacemaker output setting exceeds at least twice the measured threshold value. If the threshold exceeds 3 mA reposition the pacing lead to achieve a lower threshold. Finally, remove the sterile cover of the temporary pacing lead and fixate it using a large transparent film dressing that covers the access site and approximately 10 centimeters of the external portion of the pacing lead.
In the trial, 238 patients were randomized between the upper extremity and the lower extremity cohort for secondary access. Clinically relevant bleeding events were significantly lower in the upper extremity group compared to the lower extremity group. When the upper extremity approach was used, time to mobilization was significantly shorter in patients requiring extended pacing or temporary pacing lead backup at around 530 minutes versus 1, 415 minutes for the lower extremity group.
View the full transcript and gain access to thousands of scientific videos
Overview
This study explores an upper-extremity approach for secondary access during transfemoral transcatheter aortic valve implantation (TAVI). The method is associated with fewer bleeding complications and promotes quicker mobilization for patients requiring extended pacing.
Key Study Components
Area of Science
- Cardiovascular interventions
- Transcatheter aortic valve implantation
- Patient mobilization strategies
Background
- Transfemoral TAVI is a common procedure for aortic valve replacement.
- Secondary access site-related complications can hinder recovery.
- Early mobilization is crucial for improving patient outcomes.
- Innovative approaches are needed to enhance procedural safety and efficiency.
Purpose of Study
- To refine TAVI practices and improve overall procedural outcomes.
- To reduce complications associated with secondary access sites.
- To facilitate early mobilization and rehabilitation for patients.
Methods Used
- Upper-extremity access technique for TAVI.
- Assessment of bleeding complications at access sites.
- Evaluation of patient mobilization times post-procedure.
- Utilization of invasive hemodynamic measurements.
Main Results
- Fewer bleeding complications were observed with the upper-extremity approach.
- Patients experienced reduced time to mobilization.
- Enhanced satisfaction reported by patients and nursing staff.
- Improved diagnostic accuracy for para valvular regurgitation was achieved.
Conclusions
- The upper-extremity approach is a viable alternative for TAVI.
- It significantly reduces complications and enhances recovery.
- Further studies are warranted to validate these findings.
Frequently Asked Questions
Executive Industry Relevance
Secondary access site complications in transfemoral TAVI present a significant procedural risk, impacting patient recovery and operational efficiency. The upper-extremity approach for secondary access, as validated in the TAVI XS trial, demonstrates reduced bleeding events and enables earlier patient mobilization. This procedural refinement supports risk mitigation and enhances the reproducibility of interventional cardiovascular workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic evaluation of procedural modifications to reduce adverse event rates.
- Supports mechanistic de-risking by isolating the impact of access site selection on clinical outcomes.
- Facilitates hypothesis-driven assessment of patient mobilization strategies.
Screening & Assay Development
- Provides a reproducible protocol for secondary access site selection in interventional studies.
- Standardizes quantitative measurement of bleeding complications and mobilization times.
- Enables comparative analysis of procedural safety across access site cohorts.
Translational & Preclinical Research
- Aligns procedural innovation with translational endpoints such as early mobilization and reduced infection risk.
- Supports continuity from procedural optimization to patient-centric outcome measures.
- Informs risk-adjusted advancement of interventional device protocols.
Pipeline & Workflow Integration
The upper-extremity secondary access protocol integrates into the procedural optimization continuum, from early discovery of access site risks to validation in randomized clinical settings.
- Discovery Biology: Clarifies the mechanistic link between access site selection and bleeding risk.
- Screening: Enables standardized assessment of procedural safety and mobilization metrics.
- Analytics: Provides quantitative outputs for cross-cohort comparison of clinical endpoints.
- Translational Research: Bridges procedural refinements to improved patient recovery trajectories.
- Enterprise Reuse: Establishes a protocol adaptable across interventional cardiovascular studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in procedural safety and patient recovery outcomes.
- Operational Value: Enhances standardization, reproducibility, and scalability of access site protocols.
- Strategic Value: Supports data-driven go/no-go decisions for procedural adoption and resource allocation.
- Portfolio Impact: Reduces late-stage procedural risk and informs prioritization of interventional innovations.
Implementation Considerations
- Requires expertise in ultrasound-guided vascular access and temporary pacing lead placement.
- Demands access to fluoroscopy and hemodynamic monitoring infrastructure.
- Necessitates cross-team standardization of procedural and safety endpoints.
- Adaptable to a broad range of transfemoral TAVI patient populations.
- Dependent on institutional readiness for protocol adoption and training.
